Cathepsin B is a target of Hedgehog signaling in pancreatic cancer

Cancer Lett. 2009 Jan 18;273(2):266-72. doi: 10.1016/j.canlet.2008.08.028. Epub 2008 Nov 11.

Abstract

This study investigated the influence of cathepsin B (CATB), a downstream target of Hedgehog (Hh) signaling, in pancreatic cancer. Cyclopamine (Hh signal inhibitor) suppressed expression of Shh, as well as Hh-induced transcription factor Gli1, and induced apoptosis in Shh-positive pancreatic cancer cell line (PANC-1). Microarray analysis revealed CATB as a gene downregulated by Hh. Cyclopamine reduced CATB protein and mRNA levels. Cyclopamine or CATB inhibitor reduced PANC-1 cell invasiveness (P<0.05). CATB expression in human pancreatic cancer tissues tended to correlate with Shh expression (P=0.053). Conclusively, Hh targets CATB and Hh signaling through CATB might influence pancreatic cancer cell invasiveness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cathepsin B / metabolism*
  • Cell Line, Tumor
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Hedgehog Proteins / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms / metabolism*
  • RNA, Messenger / metabolism
  • Signal Transduction

Substances

  • Hedgehog Proteins
  • RNA, Messenger
  • SHH protein, human
  • Cathepsin B